In the current study of male HNSCC patients, we showed that FADD amplification was present in 69 of 339 cases (20.4%), and gene amplification was associated with a higher incidence of lymph node metastasis (LNM) and extracapsular spread (ECS). The gene discussed is FADD; the disease is metastatic malignant neoplasm in the lymph nodes.